Search results for "Highlights"
Studies show potential sequelae on diabetic eye from cataract surgery, GLP-1 use
One retrospective study found that progression to proliferative diabetic retinopathy was more likely after cataract surgery, while another showed that a modest increase in the risk of nonarteritic anterior ischemic optic neuropathy may be associated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide.
https://diabetes.acponline.org/archives/2025/03/14/3.htm
14 Mar 2025
One-hour glucose tolerance test accurate, convenient for postpartum assessment
The one-hour test identified dysglycemia in 60 of 70 patients who were also diagnosed by their two-hour glucose value, as well as 96 additional patients, a single-center Canadian study found.
https://diabetes.acponline.org/archives/2025/03/14/2.htm
14 Mar 2025
Model could help select initial glucose-lowering therapy for type 2 diabetes
Age, duration of diabetes, sex, baseline body mass index, and baseline levels of HbA1c, estimated glomerular filtration rate, cholesterol levels, and alanine aminotransferase were used to predict the effectiveness of five classes of diabetes drugs.
https://diabetes.acponline.org/archives/2025/03/14/1.htm
14 Mar 2025
SGLT-2 inhibitors, GLP-1 receptor agonists lower COPD exacerbation risk
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists were associated with significant reductions in severe chronic obstructive pulmonary disease (COPD) exacerbations compared with dipeptidyl peptidase-4 inhibitors, an observational study found.
https://diabetes.acponline.org/archives/2025/02/14/3.htm
14 Feb 2025
Micronutrient deficiencies, especially vitamin D, common in type 2 diabetes
Approximately 45% of patients with type 2 diabetes were deficient in multiple micronutrients, with vitamin D deficiency the most common at approximately 61%, a meta-analysis of 132 studies found.
https://diabetes.acponline.org/archives/2025/02/14/2.htm
14 Feb 2025
GLP-1 receptor agonists show effects on substance disorders, infections
Researchers should examine the effects of glucagon-like peptide 1 (GLP-1) receptor agonists on multiple diseases, according to the authors of a systematic review that looked at 175 health outcomes in patients taking diabetes medications.
https://diabetes.acponline.org/archives/2025/02/14/1.htm
14 Feb 2025
U.K. consensus statement targets potential barriers to CGM use
Primary care teams face a critical need for education, training, and resources such as electronic health record integration to increase use of continuous glucose monitoring (CGM) in type 2 diabetes, an industry-funded consensus statement said.
https://diabetes.acponline.org/archives/2025/01/10/3.htm
10 Jan 2025
Trial supports insulin as first-line treatment for gestational diabetes
Metformin plus glyburide as needed did not meet criteria for noninferiority to insulin on the outcome of the proportion of infants born large for gestational age, a multicenter trial of 820 patients in the Netherlands found.
https://diabetes.acponline.org/archives/2025/01/10/2.htm
10 Jan 2025
ADA releases updated Standards of Care for 2025
The American Diabetes Association (ADA) has added new recommendations on screening for type 1 diabetes, referring for dental care, and addressing female sexual dysfunction, among other topics.
https://diabetes.acponline.org/archives/2025/01/10/1.htm
10 Jan 2025
Inhaled insulin noninferior to usual care, industry trial in type 1 diabetes finds
Patients who began using inhaled insulin were more likely to have an improvement or worsening in their HbA1c level than patients who continued their existing insulin regimens, but overall glycemic control was similar with either strategy, a randomized trial found.
https://diabetes.acponline.org/archives/2024/12/13/3.htm
13 Dec 2024
Hypoglycemic events linked to subsequent stroke risk in diabetes
Medicare patients with diabetes who had a hypoglycemic event had higher odds of a subsequent acute ischemic stroke. Risk was highest on the day after the event and decreased with time but persisted for 30 days, the case-crossover study found.
https://diabetes.acponline.org/archives/2024/12/13/2.htm
13 Dec 2024
Diabetes rates hold steady in latest U.S. report, rising around the world
In the U.S., 11.3% of adults have diagnosed diabetes and 4.5% have undiagnosed diabetes, a CDC report found. A global analysis found that diabetes rates are rising fastest in low- and middle-income countries in southeast Asia, south Asia, the Middle East and north Africa, and Latin America and the Caribbean.
https://diabetes.acponline.org/archives/2024/12/13/1.htm
13 Dec 2024
Review calls for increased measurement, treatment of diabetes distress
An analysis of six studies found that an average of 78.3% of people with diabetes had at least some clinically relevant diabetes distress-related problems and that a commonly used scale does not capture most patients with distress.
https://diabetes.acponline.org/archives/2024/11/08/3.htm
8 Nov 2024
Dexamethasone not associated with survival benefit in inpatients with COVID-19, diabetes
Patients with diabetes and severe COVID-19 who were treated with dexamethasone had slower time to clinical recovery than propensity-matched patients who didn't get dexamethasone, and steroid treatment did not improve mortality, a retrospective study found.
https://diabetes.acponline.org/archives/2024/11/08/2.htm
8 Nov 2024
Short-term insulin followed by oral drugs provided glucose control in new type 2 diabetes
Patients with a new diagnosis of type 2 diabetes and an HbA1c level of 8.5% or greater significantly lowered their HbA1c levels if they took insulin for two to three weeks before switching to linagliptin, metformin, or both, a randomized trial in China found.
https://diabetes.acponline.org/archives/2024/11/08/1.htm
8 Nov 2024
Metformin linked with lower delirium risk in older patients with type 2 diabetes
There was a dose-response relationship between metformin and delirium in those ages 65 years and older, with higher cumulative and daily doses of the medication linked with lower delirium risk, a cohort study in Taiwan indicated.
https://diabetes.acponline.org/archives/2024/10/11/3.htm
11 Oct 2024
Diabetes-related foot ulcers associated with high short-term mortality rates
In patients with a new diabetes-related foot ulcer, mortality rates were 4.2%, 8.2%, and 14.4% at 12, 26, and 52 weeks, and even higher rates were seen with cardiovascular or renal comorbidities or older age, a study in England and Wales found.
https://diabetes.acponline.org/archives/2024/10/11/2.htm
11 Oct 2024
Risk for new-onset diabetes appears to have increased during COVID-19 pandemic
While the pandemic period was associated with more new cases of type 2 diabetes across subgroups, risk was highest among patients exposed to SARS-CoV-2, a cohort study in Florida found.
https://diabetes.acponline.org/archives/2024/10/11/1.htm
11 Oct 2024
Hyperkalemia may be less common with GLP-1s than DPP-4s
Patients with type 2 diabetes who were taking glucagon-like peptide-1 (GLP-1) receptor agonists had lower rates of hyperkalemia than those taking dipeptidyl peptidase-4 (DPP-4) inhibitors and were more likely to continue renin-angiotensin system inhibitors over the long term, a cohort study found.
https://diabetes.acponline.org/archives/2024/09/13/3.htm
13 Sep 2024
Inpatients on insulin effectively used personal CGMs during hospitalization
Most patients and nurses reported satisfaction with a protocol that allowed use of personal continuous glucose monitors (CGMs) in lieu of fingerstick blood glucose tests, a retrospective single-center study reported.
https://diabetes.acponline.org/archives/2024/09/13/2.htm
13 Sep 2024